Journal Article

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Aggarwal, Gaurav, Benoit, Stefanie, Wong, Johnny, Plebani, Mario, Vikse, Jens, Henry, Brandon Michael, Lippi, Giuseppe

2020

Overview

Coronavirus disease 2019 (COVID-19) infection has now reached a pandemic state, affecting more than a million patients worldwide. Predictors of disease outcomes in these patients need to be urgently assessed to decrease morbidity and societal burden. Lactate dehydrogenase (LDH) has been associated with worse outcomes in patients with viral infections. In this pooled analysis of 9 published studies (n = 1532 COVID-19 patients), we evaluated the association between elevated LDH levels measured at earliest time point in hospitalization and disease outcomes in patients with COVID-19. Elevated LDH levels were associated with a ~6-fold increase in odds of developing severe disease and a ~16-fold increase in odds of mortality in patients with COVID-19. Larger studies are needed to confirm these findings.

• Publisher: Elsevier Inc,Elsevier Limited
• Subject: Betacoronavirus / Biomarkers - blood / C-Reactive Protein - metabolism / Coronavirus / Coronavirus Infections - enzymology / Coronavirus Infections - epidemiology / Coronaviruses / COVID-19 / Dehydrogenase / Emergency / Emergency medical care / Global Health / Humans / L-Lactate dehydrogenase / L-Lactate Dehydrogenase - blood / Lactate dehydrogenase / Lactic acid / Morbidity / Mortality / Pandemics / Pneumonia, Viral - enzymology / Pneumonia, Viral - epidemiology / SARS-CoV-2 / Severity of Illness Index / Survival Rate - trends / Viral infections